Article
Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients.
Scientific reports - 5 Jul 2017
Raj V Stalin, Hundie Gadissa Bedada, Schürch Anita C, Smits Saskia L, Pas Suzan D, Le Pogam Sophie, Janssen Harry L A, de Knegt Rob J, Osterhaus Albert D M E, Najera Isabel, Boucher Charles A, Haagmans Bart L
Abstract excerpt
Current standard-of-care treatment of chronically infected hepatitis C virus (HCV) patients involves direct-acting antivirals (DAA). However, concerns exist regarding the emergence of drug -resistant variants and subsequent treatment failure. In this study, we investigate potential natural drug-resistance mutations in the NS5B gene of HCV genotype 1b from treatment-naïve patients. Population-based sequencing and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
